The "Rapid Start HIV Treatment Act of 2026" establishes a state rapid start program aimed at improving the treatment of HIV-positive patients in Minnesota. This program will oversee local rapid start initiatives that prioritize the immediate initiation of antiretroviral therapy (ART) within a framework of one to seven days following an HIV diagnosis or reengagement in care. The bill prohibits health plans from requiring prior authorization, step therapy, or cost-sharing for antiretroviral therapy and HIV prevention services, ensuring that patients can access necessary treatments without financial barriers. The commissioner of health is tasked with implementing the program, which includes training healthcare providers and maintaining local programs at designated HIV testing and clinical care sites.

Additionally, the bill outlines the process for determining presumptive eligibility for the AIDS Drug Assistance Program (ADAP) and mandates data collection and reporting requirements for local rapid start programs. These programs must track various metrics, including patient demographics and ART initiation timelines, and report their findings to the legislature annually. The bill also includes an appropriation from the general fund to support the implementation of these programs, ensuring that adequate resources are allocated to enhance HIV treatment and prevention efforts in the state.